{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:50:19Z","timestamp":1791967819119,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6326"],"award-info":[{"award-number":["2024JJ6326"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ6491"],"award-info":[{"award-number":["2024JJ6491"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002664","name":"Hunan Normal University","doi-asserted-by":"publisher","award":["S202410542257"],"award-info":[{"award-number":["S202410542257"]}],"id":[{"id":"10.13039\/501100002664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002664","name":"Hunan Normal University","doi-asserted-by":"publisher","award":["2024267"],"award-info":[{"award-number":["2024267"]}],"id":[{"id":"10.13039\/501100002664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002664","name":"Hunan Normal University","doi-asserted-by":"publisher","award":["2023043"],"award-info":[{"award-number":["2023043"]}],"id":[{"id":"10.13039\/501100002664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002664","name":"Hunan Normal University","doi-asserted-by":"publisher","award":["2025457"],"award-info":[{"award-number":["2025457"]}],"id":[{"id":"10.13039\/501100002664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154593","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:40:37Z","timestamp":1789515637000},"page":"154593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The emerging landscape of polymerase \u03b8 in tumor pathogenesis and precision treatment"],"prefix":"10.1016","volume":"837","author":[{"given":"Mingdian","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154593_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2012.10.004","article-title":"DNA polymerase POLQ and cellular defense against DNA damage","volume":"12","author":"Yousefzadeh","year":"2013","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbrc.2026.154593_bib2","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1093\/nar\/gkg814","article-title":"POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells","volume":"31","author":"Seki","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1097-2765(03)00006-6","article-title":"The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis","volume":"11","author":"Tanner","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib4","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1073\/pnas.062038699","article-title":"Quantitative measurement of translesion replication in human cells: evidence for bypass of abasic sites by a replicative DNA polymerase","volume":"99","author":"Avkin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib5","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1038\/sj.emboj.7600424","article-title":"High-efficiency bypass of DNA damage by human DNA polymerase Q","volume":"23","author":"Seki","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154593_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1568-7864(01)00014-3","article-title":"The \"A\" rule revisited: polymerases as determinants of mutational specificity","volume":"1","author":"Strauss","year":"2002","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbrc.2026.154593_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0300-9084(82)80138-7","article-title":"The role of DNA polymerase in base substitution mutagenesis on non-instructional templates","volume":"64","author":"Strauss","year":"1982","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2026.154593_bib8","doi-asserted-by":"crossref","first-page":"23445","DOI":"10.1074\/jbc.M604317200","article-title":"Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol","volume":"281","author":"Takata","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib9","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1021\/bi025549k","article-title":"Translesion synthesis by human DNA polymerase eta across thymine glycol lesions","volume":"41","author":"Kusumoto","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2026.154593_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117513","article-title":"DNA polymerase theta in cancer therapy: mechanism of action and modulator development","volume":"243","author":"Wu","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154593_bib11","doi-asserted-by":"crossref","first-page":"zcaf042","DOI":"10.1093\/narcan\/zcaf042","article-title":"Polymerase theta-what does it see, and why does it matter for cancer therapy?","volume":"7","author":"Ramsden","year":"2025","journal-title":"NAR Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib12","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305187120","article-title":"DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing of Rev1 and Polq in mouse embryonic stem cells","volume":"120","author":"Jiang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2025.103916","article-title":"Polymerase theta: genome protection through regulated deployment","volume":"157","author":"Smith","year":"2026","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbrc.2026.154593_bib14","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1038\/s41467-021-23463-8","article-title":"Poltheta inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance","volume":"12","author":"Zatreanu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib15","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1038\/s41467-025-61258-3","article-title":"Pol theta-mediated end-joining uses microhomologies containing mismatches","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/34593","article-title":"Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 A resolution","volume":"391","author":"Doubli\u00e9","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib17","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1038\/s41467-025-58441-x","article-title":"Structural basis for Poltheta-helicase DNA binding and microhomology-mediated end-joining","volume":"16","author":"Ito","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nature14184","article-title":"Homologous-recombination-deficient tumours are dependent on Poltheta-mediated repair","volume":"518","author":"Ceccaldi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41417-024-00815-2","article-title":"Poltheta: emerging synthetic lethal partner in homologous recombination-deficient tumors","volume":"31","author":"Bazan Russo","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2026.154593_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001005","article-title":"Dual roles for DNA polymerase theta in alternative end-joining repair of double-strand breaks in Drosophila","volume":"6","author":"Chan","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2026.154593_bib21","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.15252\/embj.201796948","article-title":"Mutational signatures of non-homologous and polymerase theta-mediated end-joining in embryonic stem cells","volume":"36","author":"Schimmel","year":"2017","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154593_bib22","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4161\/cc.7.18.6679","article-title":"DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells","volume":"7","author":"Mao","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.154593_bib23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(00)00441-X","article-title":"Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF","volume":"60","author":"Ferry","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154593_bib25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1242\/bio.018028","article-title":"Excess Poltheta functions in response to replicative stress in homologous recombination-proficient cancer cells","volume":"5","author":"Goullet de Rugy","year":"2016","journal-title":"Biol. Open"},{"key":"10.1016\/j.bbrc.2026.154593_bib26","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/nar\/gkp035","article-title":"Human DNA polymerase theta possesses 5'-dRP lyase activity and functions in single-nucleotide base excision repair in vitro","volume":"37","author":"Prasad","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molcel.2006.07.032","article-title":"Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage","volume":"24","author":"Yoshimura","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib28","article-title":"DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells","author":"Le","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2026.154593_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-024-06688-5","article-title":"Iron promotes ovarian cancer malignancy and advances platinum resistance by enhancing DNA repair via FTH1\/FTL\/POLQ\/RAD51 axis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154593_bib30","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-1519","article-title":"ALDH1A1 enhances micro homology-mediated end joining by increasing POLQ expression","volume":"82","author":"Lavudi","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41698-023-00411-x","article-title":"ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase theta expression","volume":"7","author":"Lavudi","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094591","article-title":"On Iron metabolism and its regulation","volume":"22","author":"Vogt","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib33","doi-asserted-by":"crossref","first-page":"1559s","DOI":"10.3945\/ajcn.117.155804","article-title":"Current understanding of iron homeostasis","volume":"106","author":"Anderson","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbrc.2026.154593_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100860","article-title":"Iron: the cancer connection","volume":"75","author":"Torti","year":"2020","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib36","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/1097-0142(19911201)68:11<2407::AID-CNCR2820681113>3.0.CO;2-N","article-title":"Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice","volume":"68","author":"Hann","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102416","article-title":"HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer","volume":"57","author":"Tan","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2018.03.006","article-title":"Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer","volume":"149","author":"Long","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071647","article-title":"Germline variants in cancer genes from young breast cancer Mexican patients","volume":"14","author":"G\u00f3mez-Flores-Ramos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154593_bib40","doi-asserted-by":"crossref","first-page":"zcaa013","DOI":"10.1093\/narcan\/zcaa013","article-title":"XRCC1 promotes replication restart, nascent fork degradation and mutagenic DNA repair in BRCA2-deficient cells","volume":"2","author":"Eckelmann","year":"2020","journal-title":"NAR Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib41","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.1074\/jbc.TM117.000375","article-title":"Repair of DNA double-strand breaks by mammalian alternative end-joining pathways","volume":"293","author":"Sallmyr","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.molcel.2018.12.008","article-title":"Genetic screens reveal FEN1 and APEX2 as BRCA2 synthetic lethal targets","volume":"73","author":"Mengwasser","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2017.07.001","article-title":"Smarcal1-Mediated fork reversal triggers Mre11-Dependent degradation of nascent DNA in the absence of Brca2 and stable Rad51 nucleofilaments","volume":"67","author":"Kolinjivadi","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib44","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/emboj.2009.206","article-title":"PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination","volume":"28","author":"Bryant","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2026.154593_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-biochem-062917-012415","article-title":"The MRE11-RAD50-NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair","volume":"87","author":"Syed","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2026.154593_bib46","first-page":"2585","article-title":"Microhomology-mediated end joining is activated in irradiated human cells due to phosphorylation-dependent formation of the XRCC1 repair complex","volume":"45","author":"Dutta","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib47","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1074\/jbc.RA118.005188","article-title":"DNA polymerase \u03b8 (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse","volume":"294","author":"Wang","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib48","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1038\/s41467-019-12234-1","article-title":"Genetic determinants of cellular addiction to DNA polymerase theta","volume":"10","author":"Feng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/978-1-61779-998-3_27","article-title":"I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks","volume":"920","author":"Gunn","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib50","doi-asserted-by":"crossref","first-page":"13390","DOI":"10.1073\/pnas.0910759107","article-title":"DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability","volume":"107","author":"Lemee","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41698-025-01000-w","article-title":"Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumors","volume":"9","author":"Sztupinszki","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.21873\/cgp.20458","article-title":"Induction of the DNA-Repair gene POLQ only in BRCA1-mutant breast-cancer cells by methionine restriction","volume":"21","author":"Kunihisa","year":"2024","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bbrc.2026.154593_bib53","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1073\/pnas.77.12.7306","article-title":"Reversible growth arrest in simian virus 40-transformed human fibroblasts","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib54","first-page":"272","article-title":"Synergy of combining methionine restriction and chemotherapy: the disruptive next generation of cancer treatment, cancer diagn","volume":"3","author":"Kubota","year":"2023","journal-title":"Progn"},{"key":"10.1016\/j.bbrc.2026.154593_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/geno.1999.5843","article-title":"Cloning and chromosomal mapping of the human DNA polymerase theta (POLQ), the eighth human DNA polymerase","volume":"59","author":"Sharief","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.bbrc.2026.154593_bib56","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.21873\/anticanres.15734","article-title":"Stage IV pancreatic cancer patient treated with FOLFIRINOX combined with oral methioninase: a highly-rare case with long-term stable disease","volume":"42","author":"Kubota","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib57","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.21873\/invivo.13310","volume":"37","author":"Kubota","year":"2023","journal-title":"In Vivo"},{"key":"10.1016\/j.bbrc.2026.154593_bib58","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.21873\/anticanres.16089","article-title":"Elimination of axillary-lymph-node metastases in a patient with invasive lobular breast cancer treated by first-line neo-adjuvant chemotherapy combined with methionine restriction","volume":"42","author":"Kubota","year":"2022","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib59","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.21873\/anticanres.16946","volume":"44","author":"Sato","year":"2024","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib60","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.21873\/invivo.13591","article-title":"Extensive shrinkage and long-term stable disease in a teenage female patient with high-grade glioma treated with temozolomide and radiation in combination with oral recombinant methioninase and a low-methionine diet","volume":"38","author":"Sato","year":"2024","journal-title":"In Vivo"},{"key":"10.1016\/j.bbrc.2026.154593_bib61","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/cas.15727","article-title":"Targeting polymerase \u03b8 impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma","volume":"114","author":"Rao","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib62","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1038\/oncsis.2012.29","article-title":"DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early\/mid-stage non-small cell lung cancer patients","volume":"1","author":"Allera-Moreau","year":"2012","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbrc.2026.154593_bib63","article-title":"POLQ identifies a better response subset to immunotherapy in muscle-invasive bladder cancer with high PD-L1","volume":"13","author":"Liu","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","article-title":"The challenges of tumor mutational burden as an immunotherapy biomarker","volume":"39","author":"Jardim","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib65","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jmcb\/mjaa040","article-title":"Gain-of-function mutant p53 in cancer progression and therapy","volume":"12","author":"Zhang","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71215","article-title":"Molecular characteristics and treatment implications of TP53 gain-of-function mutations in non-small cell lung cancer","volume":"14","author":"Zhao","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-018-0810-4","article-title":"The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)","volume":"17","author":"Golding","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib68","first-page":"363","article-title":"DNA polymerases in the risk and prognosis of colorectal and pancreatic cancers","volume":"34","author":"Silvestri","year":"2019","journal-title":"Mutagenesis"},{"key":"10.1016\/j.bbrc.2026.154593_bib69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12672-024-01496-x","article-title":"POLQ knockdown inhibits proliferation, migration, and invasion by inducing cell cycle arrest in colorectal cancer","volume":"15","author":"Yao","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib70","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/1078-0432.CCR-25-0379","article-title":"Identification and targeting of POLQ-Associated hereditary colorectal cancer","volume":"31","author":"Xu","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193006","article-title":"Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma","volume":"135","author":"Abeykoon","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154593_bib72","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1038\/s41598-019-39348-2","article-title":"Ortholog of the polymerase theta helicase domain modulates DNA replication in Trypanosoma cruzi","volume":"9","author":"de Lima","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212389","article-title":"Integrated multi-omics investigations of metalloproteinases in Colon cancer: focus on MMP2 and MMP9","volume":"22","author":"Buttacavoli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-026-04647-4","article-title":"Radiotherapy strategies for nonagenarian cancer patients at a tertiary cancer center","author":"Okuma","year":"2026","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib75","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1158\/1078-0432.CCR-22-2977","article-title":"Small-Molecule Pol\u03b8 inhibitors provide safe and effective tumor radiosensitization in preclinical models","volume":"29","author":"Rodriguez-Berriguete","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fonc.2018.00192","article-title":"Radiation-Induced chromosomal aberrations and immunotherapy: Micronuclei, cytosolic DNA, and interferon-production pathway","volume":"8","author":"Durante","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib77","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: an important cause of treatment failure","volume":"5","author":"Kim","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bbrc.2026.154593_bib79","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clon.2014.02.002","article-title":"The meaning, measurement and modification of hypoxia in the laboratory and the clinic","volume":"26","author":"Hammond","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.bbrc.2026.154593_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217063","article-title":"Targeting S6K\/NF\u03baB\/SQSTM1\/Pol\u03b8 signaling to suppress radiation resistance in prostate cancer","volume":"597","author":"Clark","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.canlet.2018.07.009","article-title":"Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation","volume":"433","author":"Hussain","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112231","article-title":"p62 as a therapeutic target for tumor","volume":"193","author":"Tao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib83","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2021.5257","article-title":"Sequestosome 1\/p62: a multitasker in the regulation of malignant tumor aggression","volume":"59","author":"Tang","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib84","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/febs.14712","article-title":"p62\/SQSTM1: 'jack of all trades' in health and cancer","volume":"286","author":"S\u00e1nchez-Mart\u00edn","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.154593_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2011.12.006","article-title":"KrasG12D-induced IKK2\/\u03b2\/NF-\u03baB activation by IL-1\u03b1 and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma","volume":"21","author":"Ling","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib86","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/15548627.2016.1210368","article-title":"SQSTM1\/p62 mediates crosstalk between autophagy and the UPS in DNA repair","volume":"12","author":"Hewitt","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2026.154593_bib87","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1093\/nar\/gkab262","article-title":"Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell","volume":"49","author":"Hussain","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib88","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trecan.2020.09.007","article-title":"Targeting the DNA repair enzyme polymerase \u03b8 in cancer therapy","volume":"7","author":"Schrempf","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217063","article-title":"Targeting S6K\/NFkappaB\/SQSTM1\/Poltheta signaling to suppress radiation resistance in prostate cancer","volume":"597","author":"Clark","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib90","article-title":"A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154593_bib91","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcancer.2019.12.003","article-title":"PD-L1 status in breast cancer: current view and perspectives","volume":"72","author":"Vranic","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib92","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165934","article-title":"POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS\/STING signaling","volume":"133","author":"Oh","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2026.154593_bib93","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","article-title":"PARP inhibition elicits STING-Dependent antitumor immunity in Brca1-Deficient ovarian cancer","volume":"25","author":"Ding","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib94","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-Deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2026.154593_bib95","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.celrep.2019.11.113","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"29","author":"Garcia-Diaz","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib96","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib97","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/genetics\/163.3.1031","article-title":"Phenotype-based identification of mouse chromosome instability mutants","volume":"163","author":"Shima","year":"2003","journal-title":"Genetics"},{"key":"10.1016\/j.bbrc.2026.154593_bib98","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/s41598-019-38534-6","article-title":"Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008491","article-title":"Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model","volume":"12","author":"Sun","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib100","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-025-15537-3","article-title":"Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications","author":"Shash","year":"2026","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib101","article-title":"Integrated analysis of polymerase family gene mutations in Acute Myeloid leukemia: clinical features, prognosis, and bioinformatics insights","volume":"60","author":"Wu","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.bbrc.2026.154593_bib102","first-page":"373","article-title":"Clinical Analysis of Pediatric Acute Myeloid Leukemia with CCLG-AML 2015 Regimen]","volume":"30","author":"Wang","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.bbrc.2026.154593_bib103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12887-024-04954-1","article-title":"Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.bbrc.2026.154593_bib104","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1007\/s00277-024-05939-x","article-title":"Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period-a retrospective study in two medical centers","volume":"103","author":"Xu","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbrc.2026.154593_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050722","article-title":"POLQ overexpression is associated with an increased somatic mutation load and PLK4 overexpression in lung adenocarcinoma","volume":"11","author":"Shinmura","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.154593_bib106","first-page":"523","article-title":"Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia","volume":"26","author":"Canitrot","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165954","article-title":"DNA polymerase theta repression enhances the docetaxel responsiveness in metastatic castration-resistant prostate cancer","volume":"1866","author":"Kuei","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2026.154593_bib108","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181264","article-title":"Prognostic values of E2F mRNA expression in human gastric cancer","volume":"38","author":"Manicum","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10028","article-title":"Recruitment of Pontin\/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression","volume":"6","author":"Tarangelo","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib111","first-page":"1561","article-title":"Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer","volume":"36","author":"Bae","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2026.154593_bib112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2015.03.029","article-title":"MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression","volume":"362","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib113","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1038\/onc.2016.32","article-title":"Targeting the RB-E2F pathway in breast cancer","volume":"35","author":"Johnson","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154593_bib114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.21873\/cgp.20083","article-title":"Effects of sepantronium bromide (YM-155) on the whole transcriptome of MDA-MB-231 cells: highlight on impaired ATR\/ATM Fanconi Anemia DNA damage response","volume":"15","author":"Mazzio","year":"2018","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bbrc.2026.154593_bib115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1039\/D0MD00383B","article-title":"Generation of reactive oxygen species is the primary mode of action and cause of survivin suppression by sepantronium bromide (YM155)","volume":"12","author":"Wani","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib116","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1349-7006.2010.01834.x","article-title":"Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models","volume":"102","author":"Nakahara","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib117","first-page":"569","article-title":"YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer","volume":"39","author":"Yamanaka","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib118","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1016\/j.molcel.2022.11.008","article-title":"POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells","volume":"82","author":"Belan","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib119","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nsmb.3494","article-title":"The helicase domain of Pol\u03b8 counteracts RPA to promote alt-NHEJ","volume":"24","author":"Mateos-Gomez","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib120","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/nar\/gkn184","article-title":"Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks","volume":"36","author":"Liang","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib121","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.molcel.2020.12.006","article-title":"Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD","volume":"81","author":"Hewitt","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib122","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.abb4542","article-title":"Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors","volume":"372","author":"Fugger","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154593_bib123","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cell.2018.03.050","article-title":"DNA repair network analysis reveals Shieldin as a key regulator of NHEJ and PARP inhibitor sensitivity","volume":"173","author":"Gupta","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154593_bib124","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41556-018-0140-1","article-title":"Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells","volume":"20","author":"Dev","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-018-0324-7","article-title":"53BP1-RIF1-shieldin counteracts DSB resection through CST- and Pol\u03b1-dependent fill-in","volume":"560","author":"Mirman","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","article-title":"The shieldin complex mediates 53BP1-dependent DNA repair","volume":"560","author":"Noordermeer","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib127","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-018-0362-1","article-title":"53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ","volume":"560","author":"Ghezraoui","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib128","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1021\/acs.jmedchem.2c02101","article-title":"Small molecules targeting DNA polymerase theta (POL\u03b8) as promising synthetic lethal agents for precision cancer therapy","volume":"66","author":"Pismataro","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib129","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.3390\/ijms25179134","article-title":"Correction: barszczewska-pietraszek et al. Pol\u03b8 Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells","volume":"25","author":"Barszczewska-Pietraszek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2025.104978","article-title":"Polymerase \u0472 inhibitors combinations with approved and investigational agents in patient-derived tumor multi-cell type (mct) spheroids","volume":"143","author":"Teicher","year":"2025","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbrc.2026.154593_bib131","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1021\/acs.jmedchem.2c00998","article-title":"Identification of RP-6685, an orally bioavailable compound that inhibits the DNA polymerase activity of Pol\u03b8","volume":"65","author":"Bubenik","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib132","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1038\/s41467-024-51351-4","article-title":"Structural basis for a Pol\u03b8 helicase small-molecule inhibitor revealed by cryo-EM","volume":"15","author":"Ito","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010319","article-title":"Pol\u03b8 inhibition: an anticancer therapy for HR-Deficient tumours","volume":"24","author":"Barszczewska-Pietraszek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154593_bib134","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1093\/nar\/gkad727","article-title":"Novobiocin blocks nucleic acid binding to Pol\u03b8 and inhibits stimulation of its ATPase activity","volume":"51","author":"Syed","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib135","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/acs.jmedchem.5c02689","article-title":"Discovery of SY-589, a highly potent and orally bioavailable Pol\u03b8 helicase inhibitor for the treatment of HR-Deficient tumors","volume":"69","author":"Ge","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib136","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1021\/acs.jmedchem.5c02103","article-title":"The discovery of RP-2119: a potent, selective, and orally bioavailable Pol\u03b8 ATPase inhibitor","volume":"68","author":"Mochirian","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib137","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-26-0493","article-title":"The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy","author":"Robinson","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/genes13061101","article-title":"Synthetic lethality targeting Pol\u03b8","volume":"13","author":"Drzewiecka","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbrc.2026.154593_bib139","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.aar5149","article-title":"Beyond PARP-POL\u03b8 as an anticancer target","volume":"359","author":"Higgins","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154593_bib140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2015.12.020","article-title":"Efficacy and safety of olaparib monotherapy in germline BRCA1\/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy","volume":"140","author":"Domchek","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154593_bib141","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib142","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-Mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib143","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154593_bib144","doi-asserted-by":"crossref","first-page":"21573","DOI":"10.1073\/pnas.1906120116","article-title":"Human papillomavirus 16 promotes microhomology-mediated end-joining","volume":"116","author":"Leeman","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature14157","article-title":"Mammalian polymerase \u03b8 promotes alternative NHEJ and suppresses recombination","volume":"518","author":"Mateos-Gomez","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154593_bib146","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsmedchemlett.0c00100","article-title":"From bacteria to cancer: a benzothiazole-based DNA gyrase B inhibitor redesigned for Hsp90 C-Terminal inhibition","volume":"11","author":"Pugh","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32196-6","article-title":"Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer","volume":"8","author":"Hyun","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154593_bib148","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.bmc.2018.04.028","article-title":"Exploiting polarity and chirality to probe the Hsp90 C-terminus","volume":"26","author":"Forsberg","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154593_bib149","doi-asserted-by":"crossref","first-page":"16574","DOI":"10.1002\/chem.201703206","article-title":"Development of phenyl cyclohexylcarboxamides as a novel class of Hsp90 C-terminal inhibitors","volume":"23","author":"Garg","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.bbrc.2026.154593_bib150","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1016\/j.bmcl.2017.07.030","article-title":"Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer","volume":"27","author":"Forsberg","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2026.154593_bib151","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s43018-021-00203-x","article-title":"A first-in-class Polymerase Theta Inhibitor selectively targets homologous-recombination-deficient Tumors","volume":"2","author":"Zhou","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154593_bib152","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41580-021-00405-2","article-title":"Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining","volume":"23","author":"Ramsden","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib153","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154593_bib154","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1158\/0008-5472.CAN-22-1124","article-title":"Targeting DNA repair with combined inhibition of NHEJ and MMEJ induces synthetic lethality in TP53-Mutant cancers","volume":"82","author":"Patterson-Fortin","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154593_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091310","article-title":"Polymerase \u03b8 coordinates multiple intrinsic enzymatic activities during DNA repair","volume":"12","author":"Zahn","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbrc.2026.154593_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/genes7090067","article-title":"DNA polymerase \u03b8: a unique multifunctional end-joining machine","volume":"7","author":"Black","year":"2016","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbrc.2026.154593_bib157","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1038\/s41467-023-43446-1","article-title":"Genetic separation of Brca1 functions reveal mutation-dependent Pol\u03b8 vulnerabilities","volume":"14","author":"Krais","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154593_bib158","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1073\/pnas.1213431110","article-title":"Microhomology-mediated end Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells","volume":"110","author":"Truong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154593_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101287","article-title":"Targeting DNA damage response pathways in tumor drug resistance: mechanisms, clinical implications, and future directions","volume":"83","author":"Zhu","year":"2025","journal-title":"Drug Resist. Updates"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:17:51Z","timestamp":1791965871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26013598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":159,"alternative-id":["S0006291X26013598"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154593","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging landscape of polymerase \u03b8 in tumor pathogenesis and precision treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154593"}}